Gupte, Sachin A., and Michael S. Wolin. Hypoxia promotes relaxation of bovine coronary arteries through lowering cytosolic NADPH. Am J Physiol Heart Circ Physiol 290: H2228 -H2238, 2006. First published February 3, 2006 doi:10.1152/ajpheart.00615.2005.-Hypoxia relaxes endothelium-denuded bovine coronary arteries (BCA) through mechanisms that do not appear to involve reactive oxygen species, prostaglandins, or nitric oxide. Because of similarities in the relaxation of BCA to hypoxia (PO2 ϭ 8 -10 Torr) and inhibitors of the pentose phosphate pathway (PPP) including 6-aminonicotinamide and epiandrosterone, we measured NADPH and NADP and found that hypoxia caused NADPH oxidation (decreased NADPH/NADP). The relaxation to hypoxia was similar to previously reported properties of relaxation to PPP inhibitors in that both responses were associated with glutathione oxidation and depressed intracellular calcium release and calcium influx-mediated contractile responses. Inhibitors of potassium channels had minimal effects on these relaxation responses. Relaxation to hypoxia and PPP inhibitors were attenuated by a thiol reductant (3 mM dithiothreitol) and by eliciting contraction with an activator of protein kinase C (phorbol 12,13-dibutyrate). In the presence of contraction to U-46619, relaxation to hypoxia and PPP inhibitors were attenuated by the sarco(endo)plasmic reticulum Ca 2ϩ -ATPase pump inhibitor 200 M cyclopiazonic acid and by 10 mM pyruvate. Hypoxia decreased BCA levels of glucose-6-phosphate but not ATP. Pyruvate prevented the hypoxia-elicited decrease in glucose-6-phosphate and glutathione oxidation, and it increased NADPH levels under hypoxia to levels observed under normoxia. Thus hypoxia causes a metabolic stress on the PPP that promotes BCA relaxation through processes controlled by lowering the levels of cytosolic NADPH. calcium; oxygen sensor; pentose phosphate pathway; pyruvate; sarco-(endo)plasmic reticulum calcium-adenosinetriphosphatase pump THE MECHANISM OF DILATION of systemic arteries to hypoxia has been studied since the 1880s (7); however, the fundamental processes involved in this response remain poorly understood (29, 31). In 1964 Guyton and colleagues (13) showed that autoregulation of femoral artery in the hindlimb of a dog is caused by decreasing PO 2 in vascular smooth muscle, and later it was proposed that a PO 2 sensor is present in vascular smooth muscle (4). Multiple mechanisms have been observed to be potential contributing factors to the metabolic regulation of blood flow and responses of isolated arteries to hypoxia. In the microcirculation, dilator responses to hypoxic conditions were initially attributed to factors such as a loss of ATP production, elevation in lactic acid, lowering of pH, increase in adenosine levels, and other ionic changes (14, 31). More recent studies suggested the importance of endothelial factors such as prostaglandins and nitric oxide (NO), and the opening of ATPsensitive potassium (K ATP ) channels in the response of the coronary microcirculation and isolated endothelium-intact arteries to hypoxia (2, 5, 17-19, 25, 26). It is well established that isolated endothelium-denuded arteries relax to hypoxia (2, 23, 28) through mechanisms that do not seem to result from a direct limitation of energy metabolism needed for the generation of force (3, 27) . For example, the vascular reactivity of arteries is depressed by PO 2 in the 20-to 100-Torr range, which is higher than the range generally associated with inhibition of mitochondrial oxidative phosphorylation, and arterial relaxation occurs in the presence of inhibition of respiration by cyanide (4). Some of the latest evidence suggests that PO 2 modulates the cell signaling pathways involved in excitationcontraction coupling through multiple mechanisms that control force and the regulation of intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) (30), including processes such as oxygen-dependent or ATP-dependent changes in Ca 2ϩ permeability (6, 21). Our laboratory previously showed (22, 23) that endothelium-denuded bovine coronary arteries (BCA) relax to hypoxia through unknown mechanisms that do not appear to involve changes in superoxide or peroxide and endothelium-derived mediators including prostaglandins or NO. While studying the mechanisms involved in relaxation of precontracted rat aorta and BCA to inhibitors of the pentose phosphate pathway (PPP) (9, 11), we identified a vasodilator mechanism in BCA associated with decreases in [Ca 2ϩ ] i that are controlled by the oxidation of cytosolic NADPH and glutathione (GSH) (9). Thus we investigated whether hypoxia could oxidize NADPH and/or GSH and activate relaxing mechanisms controlled by these redox cofactors. On the basis of preliminary studies that detected that hypoxia promoted a relaxation associated with oxidation of these cofactors, we developed the current study to examine whether hypoxia was causing relaxation through a metabolic process causing NADPH oxidation resembling inhibition of the PPP. Because pyruvate can potentially stabilize or enhance tissue levels of NADPH through a metabolic effect potentially associated with inhibition of phosphofructokinase (20), we examined whether pyruvate could be used as a probe to prevent NADPH oxidation and the BCA response to hypoxia.
THE MECHANISM OF DILATION of systemic arteries to hypoxia has been studied since the 1880s (7); however, the fundamental processes involved in this response remain poorly understood (29, 31) . In 1964 Guyton and colleagues (13) showed that autoregulation of femoral artery in the hindlimb of a dog is caused by decreasing PO 2 in vascular smooth muscle, and later it was proposed that a PO 2 sensor is present in vascular smooth muscle (4) . Multiple mechanisms have been observed to be potential contributing factors to the metabolic regulation of blood flow and responses of isolated arteries to hypoxia. In the microcirculation, dilator responses to hypoxic conditions were initially attributed to factors such as a loss of ATP production, elevation in lactic acid, lowering of pH, increase in adenosine levels, and other ionic changes (14, 31) . More recent studies suggested the importance of endothelial factors such as prostaglandins and nitric oxide (NO), and the opening of ATPsensitive potassium (K ATP ) channels in the response of the coronary microcirculation and isolated endothelium-intact arteries to hypoxia (2, 5, 17-19, 25, 26) . It is well established that isolated endothelium-denuded arteries relax to hypoxia (2, 23, 28) through mechanisms that do not seem to result from a direct limitation of energy metabolism needed for the generation of force (3, 27) . For example, the vascular reactivity of arteries is depressed by PO 2 in the 20-to 100-Torr range, which is higher than the range generally associated with inhibition of mitochondrial oxidative phosphorylation, and arterial relaxation occurs in the presence of inhibition of respiration by cyanide (4) . Some of the latest evidence suggests that PO 2 modulates the cell signaling pathways involved in excitationcontraction coupling through multiple mechanisms that control force and the regulation of intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) (30) , including processes such as oxygen-dependent or ATP-dependent changes in Ca 2ϩ permeability (6, 21) . Our laboratory previously showed (22, 23 ) that endothelium-denuded bovine coronary arteries (BCA) relax to hypoxia through unknown mechanisms that do not appear to involve changes in superoxide or peroxide and endothelium-derived mediators including prostaglandins or NO. While studying the mechanisms involved in relaxation of precontracted rat aorta and BCA to inhibitors of the pentose phosphate pathway (PPP) (9, 11), we identified a vasodilator mechanism in BCA associated with decreases in [Ca 2ϩ ] i that are controlled by the oxidation of cytosolic NADPH and glutathione (GSH) (9) . Thus we investigated whether hypoxia could oxidize NADPH and/or GSH and activate relaxing mechanisms controlled by these redox cofactors. On the basis of preliminary studies that detected that hypoxia promoted a relaxation associated with oxidation of these cofactors, we developed the current study to examine whether hypoxia was causing relaxation through a metabolic process causing NADPH oxidation resembling inhibition of the PPP. Because pyruvate can potentially stabilize or enhance tissue levels of NADPH through a metabolic effect potentially associated with inhibition of phosphofructokinase (20) , we examined whether pyruvate could be used as a probe to prevent NADPH oxidation and the BCA response to hypoxia.
MATERIALS AND METHODS

Materials.
Many of the reagents used in the present study were obtained from sources previously described (9, 10, 16) . DTT, reducing and protective agent for sulfydryl groups; tetraethylammonium chloride (TEA), nonspecific blocker of potassium channels; iberiotoxin (IBTX), antagonist of big-conductance calcium-activated potas-sium (KCa) channels; apamine (Apa), antagonist of small-conductance K Ca channels; glibenclamide (Gli), blocker of KATP channels; 4-aminopyridine (4-AP), blocker of voltage-sensitive potassium (K V) channels; phorbol 12,13-dibutyrate (PDBu), protein kinase C activator; EGTA, calcium chelator, pyruvate, and cyclopiazonic acid (CPA) were from Sigma. U-46619, a thromboxane A 2 analog, was from Cayman Chemical (Ann Arbor, MI), and all salts were purchased from J. T. Baker (Phillisburg, NJ).
Measurement of changes in force in BCA. Isolated endotheliumdenuded arterial rings ϳ4 mm in diameter and length were prepared from the left anterior descending artery and circumflex coronary artery of bovine calf hearts obtained from the slaughterhouse immediately after death and studied by an adaptation of previously described methods (22, 23) . Briefly, arterial rings were mounted on wire hooks attached to force displacement transducers (model FT-03, Grass) for measurements of changes in isometric force on a polygraph (model 7, Grass). Arteries were incubated for 1 h at an optimal passive tension of 5 g in individually thermostated (37°C) 10-ml baths (Metro Scientific). These studies were conducted by using Krebs bicarbonate buffer (pH 7.4), gassed with 21% O 2-5% CO2 (balance N2). The Krebs bicarbonate buffer contained the following (in mM): 118 NaCl, 4.7 KCl, 1.5 CaCl 2, 25 NaHCO3, 1.1 MgSO4, 1.2 KH2PO4, and 5.6 glucose. After a 1-h equilibration period, the vessels were depolarized with Krebs bicarbonate containing KCl in place of NaCl. This treatment produces maximal contraction and enhances the reproducibility of subsequent contractions. The arteries were then reequilibrated with Krebs solution for 30 min before the experiments were conducted. The functional removal of the endothelium by gently rubbing the lumen of the vessel was confirmed by examining the effect of 10 Ϫ8 -10 Ϫ6 M acetylcholine on arteries precontracted with 10 Ϫ7 M serotonin. Endothelium-denuded arteries did not show relaxation to acetylcholine and usually contracted to the 10 Ϫ6 M dose. After a 30-min equilibration period, experiments were conducted. In these experiments, arteries were typically precontracted to ϳ60% of maximal force (ϳ7 g) with KCl (30 mM) or other contractile agents. Once a steady-state level of force was observed, the tissue was exposed either to a vasoactive agent or to hypoxia (PO2 Х 8 -10 Torr) produced by use of a gas mixture of 95% N2-5% CO2. After a 20-min exposure to hypoxia, arteries were reoxygenated with 21% O2. The study of PO2-elicited responses was designed to minimize the influence of O2 gradients in the vessel wall on metabolism by examining a change in PO2 from 150 Torr, which is well above the PO2 range in which mitochondrial metabolism would be altered, to 8 -10 Torr, which should elicit a hypoxic metabolic response in the vessel wall. In mechanistic probing experiments, coronary arterial rings were preincubated for 30 min with various drugs (see RESULTS). None of these probes significantly altered the level of force generation to KCl.
Measurement of NADPH, NADP ϩ , and ATP in BCA. The levels of NADPH and ATP in BCA were determined by previously published HPLC methods (9, 10) . Briefly, BCA were pretreated with hypoxia in a manner similar to the studies on vascular force and immediately frozen in liquid nitrogen. The frozen tissues were crushed and homogenized in an extraction medium consisting of 0.02 N NaOH containing 0.5 mM cysteine at 0°C for measurement of NADPH. The extracts were then heated at 60°C for 10 min and neutralized with 2 ml of 0.25 M glycylglycine buffer, pH 7.6. Acidic extracts for measurements of NADP ϩ and ATP were prepared by homogenizing the tissues in hot 0.1 N HCl. The neutralized extracts were centrifuged at 10,000 g for 10 min, the supernatants were passed through 0.45-m Millipore filters, and the filtered solutions were used for measurement of NADP(H) and ATP by HPLC. NADP(H) and ATP were eluted on a reverse-phase HPLC column (4.6 ϫ 250 mm; Bondapak C18, Shiseido) at room temperature with an HP 1100 Series (Aligent Technologies) with a previously reported buffer system consisting of 100 mM potassium phosphate, pH 6.0 (buffer A) and 100 mM potassium phosphate, pH 6.0, containing 5% methanol (buffer B). The column was eluted with 100% buffer A from 0 to 8.5 min, 80% buffer A plus 20% buffer B from 8.5 to 14.5 min, and 100% buffer B from 14.5 to 40 min. The flow rate was 1.0 ml/min, and the ultraviolet absorbance was monitored at 260 nm. NADPH standards were used to calibrate the HPLC. Internal standards containing 2 nmol of NADP(H) and ATP were used to verify the quantitative recovery of the extraction procedure and HPLC retention time in the presence and absence of tissue samples.
Measurement of glutathione levels in BCA. Frozen BCA pretreated with 30 mM KCl in the absence or presence of hypoxia were crushed in liquid nitrogen, homogenized in 50 mM potassium phosphate buffer, pH 6 -7, 1 mM EDTA, and then centrifuged at 10,000 g for 15 min at 4°C. The supernatant was used for measurement of glutathione (GSH) and oxidized glutathione (GSSG) after deproteination of the sample with equal amounts of 5 g of metaphosphoric acid in 50 ml of distilled water. The samples were centrifuged at 2,000 g for at least 2 min, and the supernatant was used for GSH measurement after neutralization of the samples with 4 M triethanolamine. To estimate GSSG after separation by centrifugation and neutralization, the samples were treated with 1 M 2-vinylpyridine. GSH and GSSG were estimated with a kit purchased from Cayman Chemical.
Statistical analysis. An ANOVA statistical analysis employing a post hoc Fisher protected t-test was used for all studies on vascular contractility. All data were analyzed by Student's t-tests employing a Bonferroni correction for multiple comparisons. The acceptable level of significance was P Ͻ 0.05. The number of experimental determinations (n) in all cases is equal to the number of animals from which an arterial ring was used for a treatment or a control group in contractile studies. Values are means Ϯ SE.
RESULTS
Effects of hypoxia on NADPH, NADP
ϩ , and ATP levels in BCA. To investigate whether hypoxia affects NADPH redox and ATP levels in vascular smooth muscle, endotheliumdenuded BCA were incubated under normoxia or hypoxia in the presence of 30 mM KCl. At the end of 20-min incubation, BCA exposed to normoxia and hypoxia were homogenized, and NADPH, NADP ϩ , and ATP were measured after extraction by HPLC methods. As shown in Fig. 1 , NADPH levels decreased to ϳ30% of the normoxic value, and NADP ϩ levels accumulated in the BCA. Under these conditions, ATP levels were not altered by hypoxia. Thus hypoxia appears to promote a conversion of NADPH to NADP ϩ or an oxidation of NADPH.
Effects of hypoxia on force generation by BCA. To study the effects of hypoxia on vascular function in a systemic artery, BCA were precontracted with KCl (30 mM), U-46619 (100 nM), or PDBu (10 M) to 60 -70% of maximum force. After the contraction of each artery reached a steady-state level of force, arteries were exposed to hypoxia. As shown in Fig. 2A , exposure of BCA precontracted with 30 mM KCl or 100 nM U-46619 to hypoxia caused a relaxation of 30 -50% of the force generated by these contractile agents over the 20-min period examined. However, hypoxia did not elicit relaxation of BCA precontracted with 10 M PDBu, which induces contraction in a manner that does not appear to depend on the availability of extracellular calcium (16) . At the end of 20 min, the BCA were reexposed to 21% O 2 . As reported in previous studies (22, 23) , reoxygenation of BCA contracted with KCl and U-46619 resulted in an initial transient further relaxation during the initial 2-4 min, followed by a subsequent recovery of the levels of force observed before exposure to hypoxia (not shown). However, BCA precontracted with PDBu showed a minimal response to reoxygenation.
Effects of endothelium on hypoxia-elicited BCA relaxation.
To investigate whether an O 2 sensor is localized to endothelium or whether endothelium-derived autacoids mediate hypoxia-elicited relaxation of BCA, we exposed endotheliumintact KCl (30 mM)-preconstricted BCA rings to hypoxia. Consistent with our previous reports (22, 23) , endothelium removal did not decrease the hypoxia-elicited dilation [endothelium (ϩ) 36.0 Ϯ 2.6%, endothelium (Ϫ) 35.7 Ϯ 2.4% at 20 min] of BCA precontracted with KCl (30 mM). The presence Fig. 2 . Effects of hypoxia on force generation by BCA in the presence of contractile agents and in the absence and presence of inhibitors of cyclooxygenase, nitric oxide synthase, and K ϩ channels. A: BCA precontracted with 30 mM KCl (n ϭ 29) and 100 nM U-46619 (n ϭ 25) relaxed to hypoxia in a time-dependent manner. However, BCA precontracted with 10 M phorbol 12,13-dibutyrate (PDBu; n ϭ 33) did not relax under hypoxia. B: response to hypoxia in BCA precontracted with 30 mM KCl in the absence or presence of either 10 M indomethacin (Indo; n ϭ 10) or 100 M nitro-L-arginine (L-NNA; n ϭ 9). Indo and L-NNA did not modulate the relaxation to hypoxia. C: response to hypoxia in BCA precontracted with 100 nM U-46619 in the absence or presence of various specific and nonspecific K ϩ channel blockers. As shown, tetraethylammonium chloride (TEA, 10 mM; n ϭ 27), a nonspecific K ϩ channel blocker, glibenclamide (Gli, 10 M; n ϭ 8), an ATP-sensitive K ϩ channel blocker, 4-aminopyridine (4-AP, 10 mM; n ϭ 9), a voltage-sensitive K ϩ channel blocker, iberiotoxin (IBTX, 23 M; n ϭ 10), a big-conductance calcium-sensitive K ϩ (KCa) channel blocker, and apamine (Apa, 100 nM; n ϭ 8), a small-conductance KCa channel blocker, did not decrease the relaxation to hypoxia. Fig. 1 . Effects of hypoxia on bovine coronary artery (BCA) NADP(H) redox and ATP levels. In the presence of 30 mM KCl, hypoxia significantly decreased NADPH levels (A; n ϭ 10 -18). In contrast, NADP ϩ levels (B; n ϭ 5-10) were increased by 3-fold. However, ATP levels (C; n ϭ 5-10) remained unaltered by the 20-min hypoxic treatment. Con, control.
of endothelium also did not influence the relaxation induced by hypoxia in U-46619-preconstricted coronary artery rings.
Effects of indomethacin and nitro-L-arginine on hypoxiaelicited BCA relaxation. The effects of indomethacin (10 M), a cyclooxygenase inhibitor, and nitro-L-arginine (100 M), a NO synthase inhibitor, on hypoxic relaxation were examined to detect whether prostaglandins and NO contributed to the observed relaxation. These agents did not affect force generation in the endothelium-denuded arteries studied (not shown). Consistent with our previous reports (22, 23) in which we showed that prostaglandins and NO do not mediate hypoxic relaxation in endothelium-intact BCA, pretreatment with indomethacin and nitro-L-arginine did not significantly alter the relaxation of endothelium-denuded BCA to hypoxia (see Fig. 2B ).
Effects of K ϩ channel blockers on hypoxia-elicited BCA relaxation. Because it is possible that opening of K ATP or K Ca channels due to hypoxia may hyperpolarize vascular smooth muscle and elicit relaxation, we investigated the effects of K ϩ channel blockers on the relaxation elicited by hypoxia (Fig.  2C ). As previously reported (9, 16) , the K ϩ channel inhibitors examined did not significantly affect force generation in BCA (not shown). The nonspecific K ϩ channel blocker TEA (10 mM; Ref. 24) did not antagonize the BCA relaxation caused by hypoxia. In contrast, it appeared to slightly enhance the relaxation of BCA under hypoxia, but this effect was not statistically significant. Moreover, the K ATP , K V , big-conductance K Ca , and small-conductance K Ca channel antagonists Gli (10 M), 4-AP (10 mM), IBTX (23 M), and Apa (100 nM), respectively, also did not decrease the relaxation of BCA induced by hypoxia. Furthermore, we did not notice any effects of these drugs on the transient relaxation during posthypoxic reoxygenation (not shown).
Effects of hypoxia on contraction to different types of stimuli elicited in Ca 2ϩ -free solution followed by addition of CaCl 2 . In this series of experiments, vessels were first contracted with KCl (30 mM) in normal Krebs solution, followed by washout, and subsequent contractile responses produced by various contractile agents were studied with the protocols described below. BCA were then placed in Ca 2ϩ -free Krebs solution containing EGTA (0.1 mM), and the contractile effects of U-46619 (100 nM), 5-hydroxytryptamine (5-HT; 10 M), and KCl (30 mM) were examined in the absence or presence of hypoxia, followed by addition of CaCl 2 (1.5 mM) to detect contractile responses originating from the initial release of intracellular Ca 2ϩ and the subsequent influx of extracellular Ca 2ϩ , respectively. Hypoxia was induced 10 -15 min before the application of contractile agents, and the initial transient increase in force on addition of contractile agents was observed for ϳ15 min before the addition of CaCl 2 , when force had returned to a steady state at close to baseline levels. A typical experimental recording for responses to 5-HT is shown in Fig.  3A . The data in Fig. 3B show BCA responses to U-46619 (100 nM) and 5-HT (10 M) in Ca 2ϩ -free solution and the subsequent contraction elicited by the addition of CaCl 2 (1.5 mM) either in normoxia or hypoxia (Fig. 3C) . In normoxia, U-46619 and 5-HT caused rapid transient contraction, and sustained increases in force were observed on readdition of CaCl 2 . In the presence of hypoxia, the initial transient contraction was significantly decreased, and subsequent contraction elicited by CaCl 2 was also inhibited (Fig. 3B) . The addition of KCl (30 mM) to Ca 2ϩ -free Krebs buffer did not elicit a contraction.
Subsequent addition of CaCl 2 (1.5 mM) caused a sustained contraction in normoxia; however, this sustained contraction was markedly inhibited by hypoxia (Fig. 3C) . Effects of sarco(endo)plasmic reticulum Ca 2ϩ -ATPase pump inhibitor on hypoxia-elicited BCA relaxation. Because the sarco(endo)plasmic reticulum Ca 2ϩ -ATPase (SERCA) pump is a key site of calcium regulation by multiple signaling systems, we investigated whether inhibiting calcium uptake by this pump with 200 M CPA altered relaxation to hypoxia. Addition of CPA elicited transient contraction. After the force returned to baseline, BCA were contracted with U-46619 to study the relaxation on exposure to hypoxia. The data in Fig. 4 suggest that CPA attenuated both the hypoxia-induced response and the relaxation elicited by the PPP inhibitors 1 mM 6-aminonicotinamide (6-AN) and 0.1 mM epiandrosterone in BCA precontracted with U-46619. Furthermore, the effects of CPA on contractions under Ca 2ϩ -free conditions and after Ca 2ϩ readdition were examined. Inhibition of SERCA by CPA did not alter the contraction to U-46619 in Ca 2ϩ -free buffer under normoxic or hypoxic conditions (see Fig. 5 ). However, although CPA did not alter the contraction to 10 M 5-HT in Ca 2ϩ -free buffer under normoxic conditions (4.43 Ϯ 1.48 g, n ϭ 5), contraction to 5-HT under hypoxic conditions (3.20 Ϯ 1.65 g, n ϭ 5) was increased (P Ͻ 0.05) by CPA (7.27 Ϯ 2.97 g, n ϭ 5) in a manner that attenuated the effects of hypoxia. As shown in Fig. 5B , CPA increased the contraction elicited by Ca 2ϩ readdition in the presence of U-46619 under hypoxic conditions, suggesting that hypoxia was eliciting an enhancement of Ca 2ϩ uptake by the SERCA pump. In the presence of 5-HT, CPA did not enhance depressed contraction to Ca 2ϩ readdition observed under hypoxia, and it appeared to delay, without significantly inhibiting, relaxation to hypoxia in the presence of Krebs buffer containing normal levels of Ca 2ϩ (not shown), suggesting that changes in SERCA by hypoxia do not have a detectable effect of force generation by 5-HT associated with mechanisms dependent on Ca 2ϩ influx. Thus, given the actions of CPA, hypoxia may be stimulating Ca 2ϩ uptake by SERCA. However, the impact of hypoxia on regulating contractile responses through SERCA seems to depend on the role of the SERCA pump in contributing to the actions of each contractile agent examined.
Effects of hypoxia on GSH and GSSG levels in BCA. It is well known that NADPH is an important cofactor for the enzyme glutathione reductase, which reduces oxidized glutathione to its reduced form and maintains the GSH redox homeostasis (8) . Because our preliminary results indicated that hypoxia was decreasing the levels of NADPH in BCA, we anticipated that GSH oxidation might be detected under hypoxic conditions. As anticipated, GSSG levels were elevated significantly in BCA by 20-min hypoxia, associated with a detectable decrease in GSH (Fig. 6A) .
Effects of DTT on BCA relaxation to hypoxia. Because hypoxia appeared to oxidize GSH in BCA, BCA were pretreated with a thiol-reducing agent, 3 mM DTT, to examine whether changes in thiol redox contribute to the relaxation that is observed. This concentration of DTT was observed to reverse the effects of a thiol oxidant diamide in BCA (16) . DTT protects thiol groups from oxidation, and it also reduces the GSSG or oxidized thiols on proteins to their reduced state (8) . Pretreatment of BCA precontracted with KCl (30 mM) or U-46619 (100 nM) with DTT reduced the subsequent relax-ation elicited by hypoxia, without altering force generation under normoxic conditions (Fig. 6B) . This thiol reductant also inhibited the relaxation caused by posthypoxic reoxygenation (not shown).
Effects of glucose removal on influence of hypoxia on NADPH levels and force in BCA. In vascular smooth muscle, glucose is classically metabolized through glycolysis and PPP. Therefore, the effects of removal of glucose from the extracellular solution on NADPH generation were examined in the presence of 100 nM U-46619 (see Fig. 7 ). Under normoxic conditions, incubation of BCA in glucose-free Krebs appeared to decrease NADPH levels [glucose(ϩ) 3.47 Ϯ 0.79 nmol/g, glucose(Ϫ) 2.61 Ϯ 0.61 nmol/g; n ϭ 14], but this decrease was not statistically significant. However, under hypoxic conditions NADPH levels were significantly decreased by incubating BCA in glucose-free Krebs solution for 20 min [glucose(Ϫ): 0.28 Ϯ 0.19 nmol/g] vs. glucose-containing Krebs solution [glucose(ϩ): 1.61 Ϯ 0.75 nmol/g]. Exposure of BCA incubated in glucose-free solution to hypoxia significantly enhanced hypoxia-elicited relaxation. Although glucose-free Krebs appeared to decrease force generation to 100 nM U-46619 (see Fig. 7A ), this decrease was not statistically significant. Hypoxia did not alter ATP levels in glucose-free treated tissues (Fig. 7C) . In addition, in these experiments, the contractile agent used did not influence NADPH levels, because the NADPH levels reported in these experiments in the presence of glucose and 100 nM U-46619 under normoxia were not significantly different from BCA treated with 30 mM KCl under similar conditions (see Fig. 1A) .
Effects of inhibition of mitochondria with sodium cyanide and glycolysis with 2-deoxyglucose on hypoxic dilation.
To investigate the role of glycolysis and mitochondria in mediating hypoxic dilation of BCA, we examined the effects of sodium cyanide (10 M; n ϭ 5) and 2-deoxyglucose (2 mM; n ϭ 5) on contraction and relaxation of BCA. As previously reported (9) , pretreatment of BCA with cyanide or deoxyglucose does not suppress force generation in BCA contracted with KCl or U-46619. 2-Deoxyglucose and cyanide did not significantly change relaxation elicited by hypoxia (Fig. 8) .
Effects of pyruvate on influence of hypoxia on NADPH and glucose-6-phosphate levels and force in BCA. Pyruvate is a glycolytic metabolite that may also stabilize NADPH by inhibiting phosphofructokinase and promoting glucose metabolism through the PPP (20) . To investigate whether pyruvate shunts glucose through PPP, we measured NADPH and glucose-6-phosphate (G-6-P) levels. As demonstrated by the data shown in Fig. 9 , pyruvate (10 mM) pretreatment significantly increased NADPH and G-6-P levels in BCA under normoxia. Hypoxia did not decrease the levels of G-6-P in the presence of pyruvate. Although hypoxia caused a small, but statistically significant, decrease in the levels of NADPH in the presence of pyruvate, NADPH levels under hypoxia remained significantly greater than the levels of NADPH seen under normoxia in the absence of pyruvate. However, pyruvate only partially restored the NADPH levels that were decreased by the PPP inhibitor 6-AN (5 mM 6-AN: NADPH ϭ 0.87 Ϯ 0.27 nmol/g; pyruvate ϩ 6-AN: NADPH ϭ 1.95 Ϯ 0.37 nmol/g). As shown in Fig. 10 , pyruvate prevented detection of the increased levels of GSSG that were observed in the presence of hypoxia or 6-AN. As shown in Fig. 11 , treatment of BCA with pyruvate abolished relaxation to hypoxia and attenuated relaxation to PPP inhibitors (6-AN and epiandrosterone). Thus pyruvate had effects on attenuating relaxation to hypoxia and PPP inhibitors that were similar to its ability to prevent decreases in NADPH.
Effects of pyruvate on contraction to different types of stimuli elicited in Ca
2ϩ -free solution followed by addition of CaCl 2 under normoxia and hypoxia. The influence of 10 mM pyruvate on the contractile effects of 100 nM U-46619, 10 M 5-HT, and 30 mM KCl on BCA pretreated with Ca 2ϩ -free Krebs solution containing EGTA (0.1 mM), followed by addition of CaCl 2 (1.5 mM), was examined under normoxia and hypoxia with the protocol used for the data in Fig. 3 changed by pretreatment of BCA with pyruvate. In the presence of hypoxia, the initial transient contraction remained significantly decreased in the presence of pyruvate; however, subsequent depression by hypoxia of contraction to the addition of CaCl 2 in the presence of U-46619 and 5-HT was not observed in the presence of pyruvate (Fig. 12) . The absence of contraction to 30 mM KCl under Ca 2ϩ -free conditions was not altered by pyruvate. The subsequent sustained contraction on addition of 1.5 mM CaCl 2 under normoxia was not altered by pyruvate. However, the inhibition of contraction to the addition of 1.5 mM CaCl 2 in the presence of 30 mM KCl by hypoxia remained significantly inhibited in the presence of pyruvate, but the amount of inhibition was decreased by pyruvate (Fig.  12C) . Thus pyruvate caused a significant enhancement of force generation elicited by CaCl 2 readdition under hypoxia in the presence of all of the contractile agents examined (Fig. 12C) .
DISCUSSION
A key finding in this study is that exposure of BCA to hypoxia significantly oxidized NADPH and GSH, without altering ATP levels, activating a relaxing mechanism shown in Fig. 13 that resembles a response elicited by inhibition of the PPP. Because of the relatively low levels of mitochondria in vascular smooth muscle, the majority of NADPH and GSH measured is likely to be under the influence of cytosolic control mechanisms that maintain the redox status of these systems. Because hypoxia decreased G-6-P, it appears that hypoxia is promoting cytosolic NADPH oxidation through a metabolic depression of the availability of adequate substrate for NADPH production by the G-6-P dehydrogenase reaction of the PPP. Pyruvate was observed to increase both G-6-P and NADPH and to attenuate the loss of these metabolites seen on exposure to hypoxia. Because pyruvate also attenuated relaxation to hypoxia, the control of NADPH generation by the PPP appears to be a novel primary process regulating the relaxation of BCA by hypoxia. Fig. 7 . Effect of glucose-free conditions on hypoxia-elicited relaxation and NADPH and ATP levels. A: hypoxic relaxation was enhanced in glucose-free [glucose (Ϫ)] solution (n ϭ 10). Force generation to 100 nM U-46619 (11 Ϯ 2 g) was not altered by the absence of glucose (9 Ϯ 3 g). B: incubation of BCA (n ϭ 14) with U-46619 in glucose-free Krebs solution under hypoxic conditions for 20 min decreased NADPH levels. C: ATP levels were not altered by 20 min of hypoxia under the glucose-free conditions examined. Fig. 6 . Effects of hypoxia on BCA GSH redox and attenuation of BCA relaxation to hypoxia by DTT. A: GSH levels (n ϭ 7) were significantly decreased under hypoxia. In contrast, the GSSG levels (n ϭ 7) were increased by the 20-min hypoxic treatment. B: BCA were precontracted with 100 nM U-46619 (n ϭ 10) in the absence and presence of 3 mM DTT and then exposed to hypoxia. DTT pretreatment significantly attenuated the relaxation of BCA to hypoxia. Force generation to 100 nM U-46619 (11 Ϯ 2 g) was not altered by the presence of DTT (12 Ϯ 4 g).
Metabolism is known to be closely linked to contractile function in smooth muscle; however, its role as a regulatory mechanism is less well defined. The evidence in the present study indicates that the ATP levels in BCA were not altered during 20 min of hypoxia, and this observation is consistent with a recent report that also showed that hypoxia does not change the ATP and P i levels in porcine coronary artery (28) . Therefore, the relaxation of BCA to hypoxia cannot be attributed to loss of the ability to maintain ATP levels during contraction. Furthermore, this conclusion is supported by our observation that hypoxia does not alter force generation in BCA contracted by activating protein kinase C with PDBu. The changes in the force generation of BCA to hypoxia are not influenced by the endothelium or by vascular smooth musclederived prostaglandins and NO. These observations are consistent with our previous studies (22, 23) , which demonstrated that prostaglandins, NO, superoxide, and hydrogen peroxide do not mediate hypoxia-elicited relaxation of BCA.
Relaxation of BCA to hypoxia shows many mechanistic similarities to the response elicited by inhibition of the G-6-P dehydrogenase reaction in the PPP with the 6-AN and epiandrosterone pharmacological probes in BCA and rat aorta and pulmonary arteries (9, 11) . Both hypoxia and PPP inhibition decrease the contraction mediated by KCl and U-46619, without markedly attenuating the force generated by activation of protein kinase C with PDBu. These relaxation responses of BCA were associated with NADPH and GSH oxidation, and treatment with the thiol reductant DTT attenuates relaxation to both PPP inhibitors (9) and hypoxia. Relaxation of BCA to hypoxia and PPP inhibitors (9) does not seem to be mediated through mechanisms dominated by the opening of K ϩ channels, because none of the K ϩ channel antagonists was observed to have prominent effects on the responses that were observed. Although a previous study reported that hypoxia produces minimal (18%) relaxation of porcine coronary artery by opening K V channels (28), we could not detect a significant role for the involvement of K ϩ channels in mediating the relaxation of BCA to hypoxia under the conditions examined in the present study. Both hypoxia and PPP inhibitors (9) attenuate the contraction of BCA elicited by U-46619 and 5-HT in Ca 2ϩ -free Krebs solution and the recovery of force on readdition of 1.5 mM Ca 2ϩ with KCl, U-46619, and 5-HT. Hypoxia appeared to inhibit Ca 2ϩ influx because it attenuated contractile responses associated with Ca 2ϩ addition to BCA exposed to contractile agents under Ca 2ϩ -free conditions in a manner similar to PPP inhibitors. It was previously reported that PPP inhibition (9) and a thiol oxidant diamide (16) attenuate contractile responses mediated by Ca 2ϩ influx through both voltage-dependent and receptor-regulated calcium channels and that PPP inhibitors suppress L-type Ca 2ϩ currents (12) . Data in the present study also show that the SERCA pump inhibitor CPA attenuated relaxation to hypoxia and PPP inhibition with Fig. 8 . Effect of sodium cyanide (NaCN) and deoxyglucose on hypoxic dilation of BCA. Mitochondrial inhibitor 10 M NaCN (n ϭ 4) and glycolytic pathway inhibitor 2 mM 2-deoxyglucose (2-DG; n ϭ 5) did not significantly change relaxation of BCA to hypoxia. Fig. 9 . Effect of pyruvate on NADPH and glucose-6-phosphate (G-6-P) levels in the absence and presence of hypoxia. Pretreatment of BCA with 10 mM pyruvate (n ϭ 5) for 1 h increased NADPH (A) and G-6-P (B) under normoxic and hypoxic conditions and prevented the decrease in G-6-P caused by hypoxia.
6-AN and epiandrosterone in BCA precontracted with U-46619. Because the SERCA pump is a major site of redox regulation of Ca 2ϩ reuptake by the sarcoplasmic reticulum (SR) (1), accelerated SR Ca 2ϩ uptake by hypoxia and perhaps control of the influx of Ca 2ϩ by the Ca 2ϩ storage capacitive properties of the SR may be important factors contributing to the regulation of force generation by controlling the availability of intracellular Ca 2ϩ in BCA contracted with agents such as U-46619. Thus redox regulation of Ca 2ϩ -dependent contractile mechanisms by hypoxia is similar to those controlled by NADPH generation by the PPP, and hypoxia may coordinate these NADPH redox-controlled mechanisms associated with lowering intracellular Ca 2ϩ through processes included in the model shown in Fig. 13 .
The effects of altering aspects of glucose metabolism suggest that hypoxia is controlling the maintenance of cytosolic NADPH by the PPP. Hypoxia was observed to cause an oxidation of NADPH in BCA that was enhanced by glucosefree conditions and inhibited by pyruvate, suggesting that glucose metabolism was controlling the ability of hypoxia to regulate NADPH. Because glucose-free conditions and pyruvate enhanced and inhibited, respectively, the relaxation to hypoxia, the oxidation of NADPH appears to be closely associated with the decrease in force that is observed. The inhibitor of glycolysis 2-deoxyglucose would not be expected to deplete NADPH because its key metabolite 2-deoxyglucose-6-phosphate is a substrate for NADPH generation by G-6-P dehydrogenase. Hypoxia decreased G-6-P levels, suggesting that a decreased availability of substrate for the PPP could be an important factor associated with NADPH oxidation. Pyruvate increased G-6-P levels and prevented the decrease caused by hypoxia. Although pyruvate could have multiple metabolic actions that affect tissue NADPH levels (20) , it appears to be functioning in BCA by increasing the availability of G-6-P for the generation of NADPH by the G-6-P dehydrogenase reaction of the PPP and inhibiting processes involved in the response to hypoxia (see Fig. 13 ) through maintaining increased levels of cytosolic NADPH. Thus hypoxia appears to be causing relaxation through a metabolic effect on the maintenance of NADPH by the PPP.
Metabolic inhibitors influence force generation in BCA and the response to hypoxia in a manner that provides information on how hypoxia is promoting relaxation. Because mitochondrial inhibitors do not cause a depression of force in a manner similar to hypoxia in BCA (9), the PO 2 requirement for mitochondrial energy metabolism is not a primary factor in eliciting the relaxation to hypoxia. When the PPP was discovered (32), it was initially thought to be a direct oxidation pathway for the metabolism of carbohydrate (15) . Although the initial investigation of the oxidative dependence of this pathway focused on identifying a cytochrome-containing electron transport chain that transferred electrons from NADPH to oxygen, studies that evolved focused on the intermediates in the PPP and how they functioned in cellular metabolism (15) . The PO 2 dependence of a system oxidizing NADPH by molecular oxygen would be an attractive mechanism for explaining the relaxation to hypoxia; however, there is little evidence for a system that oxidizes NADPH as PO 2 decreases. Our study has detected evidence that GSH oxidation occurs under hypoxia and that reactive oxygen species (ROS) levels in BCA decrease either under hypoxia (22, 23) or as NADPH levels decrease when the PPP is inhibited (9, 11) . Thus a ROS-independent mechanism of oxidizing NADPH and GSH may be involved in the mechanism of sensing hypoxia in BCA. It is well established that hypoxia can promote oxidative conditions that have been thought to be mediated through the generation of ROS. How- Fig. 12 . Effects of hypoxia on the BCA force generation to contractile agents under Ca 2ϩ -free conditions and on readdition of CaCl2 after pyruvate pretreatment. A: summary data for force generation under Ca 2ϩ -free conditions in the presence of pyruvate under normoxic and hypoxic conditions resulting from the transient contractions elicited by the addition of 30 mM KCl (n ϭ 10), 100 nM U-46619 (n ϭ 5), and 10 M 5-HT (n ϭ 5). In the presence of 10 mM pyruvate, KCl did not elicit a contraction, and force generation during the transient contractions to U-46619 and 5-HT were partially attenuated by hypoxia. B: summary data for force generation in the presence of pyruvate under normoxic and hypoxic conditions resulting from the readdition of 1.5 mM CaCl2 to Ca 2ϩ -free Krebs after the transient contractions decayed to near-baseline conditions. Hypoxia partially inhibited force generation in the presence of KCl, but it did not significantly inhibit force generation caused by readdition of Ca 2ϩ in the presence of U-46619 and 5-HT in the presence of pyruvate. C: summary data for the effects of pyruvate on force generation by the readdition of Ca 2ϩ under hypoxic conditions. Pyruvate significantly enhanced force generation to the readdition of Ca 2ϩ in the presence of KCl, U-46619, and 5-HT. Fig. 13 . Model showing regulatory mechanisms that appear to influence the relaxation of BCA to hypoxia. Hypoxia was observed to decrease G-6-P and oxidize NADPH and GSH in a manner reversed by pyruvate. The effects of hypoxia appeared to mimic the effects of inhibitors of the PPP of G-6-P metabolism in causing an oxidation of NADPH and GSH associated with coordinating a depression of contractions related to the release of intracellular Ca 2ϩ and the influx of extracellular Ca 2ϩ . The actions of the SERCA inhibitor CPA suggest that stimulation of Ca 2ϩ reuptake is one of the mechanisms contributing to the actions of these redox changes elicited by hypoxia. Although the actual sensor for hypoxia remains to be identified, it appears to be associated with processes controlling the maintenance of G-6-P by glycolysis and perhaps systems independent of mitochondrial respiration and the generation of reactive oxygen species, which remain to be identified, that could promote NADPH and/or GSH oxidation under hypoxia. [Ca 2ϩ ]i, intracellular Ca 2ϩ concentration. SR, sarcoplasmic reticulum.
ever, our studies may be detecting evidence of an alternative mechanism for hypoxia producing oxidative conditions originating from the oxidation of NADPH, which may be functioning as a PO 2 sensor in BCA. Relaxation of BCA to hypoxia appears to be mediated through a novel mechanism independent of mitochondrial energy metabolism and changes in the generation of ROS, involving a process through which decreased PO 2 promotes cytosolic NADPH oxidation. Lower levels of G-6-P dehydrogenase in BCA compared with bovine pulmonary arteries (which do not relax to hypoxia) (10) and the decrease in G-6-P by hypoxia provide evidence for a decrease in the flux of glucose metabolism through the PPP as a key component in the mechanism of NADPH oxidation and the relaxation of BCA to hypoxia that is observed. Because stabilization of G-6-P levels by pyruvate maintains NADPH levels and attenuates relaxation to hypoxia, the control of G-6-P by glycolysis seems to be a major influential factor in the processes controlled by decreased PO 2 . However, GSH oxidation observed under hypoxia and NADPH still shows a small oxidation in the presence of pyruvate-elicited increases in G-6-P, suggesting that an oxygen-sensitive process promoting NADPH oxidation under hypoxia is also a potential contributing factor to the PO 2 sensor for hypoxia in BCA. Because pyruvate has been observed to attenuate functional increases in blood flow associated with the detection of redox changes linked to tissue hypoxia (33), the vascular smooth muscle PO 2 -sensing mechanism reported in the present study associated with promoting cytosolic NADPH oxidation may be a fundamental mechanism of controlling blood flow and sensing cellular hypoxia.
